Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 3
2006 3
2007 6
2008 5
2009 9
2010 5
2011 10
2012 5
2013 14
2014 6
2015 13
2016 10
2017 17
2018 13
2019 20
2020 12
2021 18
2022 14
2023 17
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Results by year

Filters applied: . Clear all
Page 1
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016.
Gien LT, Enserro DM, Block MS, Waggoner S, Duska LR, Wahner-Hendrickson AE, Thaker PH, Backes F, Kidd M, Muller CY, DiSilvestro PA, Covens A, Gershenson DM, Moore KN, Aghajanian C, Coleman RL. Gien LT, et al. Among authors: thaker ph. Gynecol Oncol. 2024 Apr 10;186:61-68. doi: 10.1016/j.ygyno.2024.03.027. Online ahead of print. Gynecol Oncol. 2024. PMID: 38603953
In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy.
Corvigno S, Badal S, Spradlin ML, Keating M, Pereira I, Stur E, Bayraktar E, Foster KI, Bateman NW, Barakat W, Darcy KM, Conrads TP, Maxwell GL, Lorenzi PL, Lutgendorf SK, Wen Y, Zhao L, Thaker PH, Goodheart MJ, Liu J, Fleming N, Lee S, Eberlin LS, Sood AK. Corvigno S, et al. Among authors: thaker ph. NPJ Precis Oncol. 2023 Nov 3;7(1):115. doi: 10.1038/s41698-023-00454-0. NPJ Precis Oncol. 2023. PMID: 37923835 Free PMC article.
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes.
Whelan K, Dillon M, Strickland KC, Pothuri B, Bae-Jump V, Borden LE, Thaker PH, Haight P, Arend RC, Ko E, Jackson AL, Corr BR, Ayoola-Adeola M, Wright JD, Podwika S, Smitherman C, Thomas S, Lightfoot M, Newton M, Washington C, Mullen M, Cosgrove C, Harsono AAH, Powell K, Herzog TJ, Salani R, Alvarez Secord A. Whelan K, et al. Among authors: thaker ph. Gynecol Oncol. 2023 Nov;178:44-53. doi: 10.1016/j.ygyno.2023.09.009. Epub 2023 Sep 23. Gynecol Oncol. 2023. PMID: 37748270
Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair gene mutation.
Toboni MD, Wu S, Farrell A, Xiu J, Ribeiro JR, Oberley MJ, Arend R, Erickson BK, Herzog TJ, Thaker PH, Powell MA. Toboni MD, et al. Among authors: thaker ph. Gynecol Oncol. 2023 Oct;177:132-141. doi: 10.1016/j.ygyno.2023.08.015. Epub 2023 Sep 8. Gynecol Oncol. 2023. PMID: 37683549
178 results